Closed System Transfer Devices (CSTD) Market
完整報告名稱與涵蓋範圍
Closed System Transfer Devices (CSTD) Market Size, Share & Trends Analysis Report, By Device Type (Membrane-to-Membrane Systems, Needleless and Luer-Lock Systems, Vial Adaptors and Access Devices, Syringe and Bag Spike Connectors), By Component (Vial Access Devices, Syringe Safety Devices, Bag and Line Access Devices, Accessories), By Application (Hazardous Drug Compounding and Administration (Oncology), Antiviral, Immunosuppressant and Other Hazardous Drugs, Veterinary Oncology and Other Applications), By End User, By Region, and Segment Forecasts, 2026-2035
報告摘要
The closed system transfer devices market covers membrane-to-membrane, needleless and luer-lock systems, vial adaptors, syringe safety devices and bag and line access components that prevent the escape of hazardous drug vapors and aerosols and the entry of contaminants during compounding and administration, used primarily for oncology and other hazardous drugs in hospitals, infusion centers and home care. Personal protective equipment, biological safety cabinets and general infusion sets are excluded.
Demand is driven by regulations and standards requiring closed systems for hazardous drug handling, including compounding standards in the United States and occupational safety guidance in Europe and Asia, by rising oncology infusion volumes and by evidence of healthcare worker exposure to antineoplastic agents. Manufacturers compete on containment performance validated under recognised protocols, compatibility with drug vials and infusion systems, ease of use and cost per dose, while hospitals evaluate total cost across compounding and administration. Innovation focuses on air-cleaning and physical barrier designs, universal connectors, reduced drug waste and integration with robotic compounding, and adoption is extending to veterinary oncology and to home infusion of hazardous medicines.
North America leads through regulatory enforcement, with Europe expanding under worker protection directives and Japan, Australia and the Middle East adopting standards. Competition involves infusion and medication delivery leaders, closed system specialists and Asian device manufacturers.
The InsightAce study delivers revenue forecasts in US$ across all device type, component, application and end user and regional segments for 2026-2035, alongside segment-level trend analysis, competitive landscape assessment and detailed company profiling.
授權報價
| Single User | $4,500 USD |
| Enterprise / Global Site Licence | $9,500 USD |
目錄 Table of Contents
Chapter 1. Methodology and Scope
1.1. Research Methodology
1.2. Research Scope & Assumptions
Chapter 2. Executive Summary
Chapter 3. Global Closed System Transfer Devices (CSTD) Market Snapshot
Chapter 4. Global Closed System Transfer Devices (CSTD) Market Variables, Trends & Scope
4.1. Market Segmentation & Scope
4.2. Market Drivers
4.3. Market Challenges
4.4. Emerging Trends
4.5. Investment and Funding Analysis
4.6. Industry Analysis - Porter's Five Forces Analysis
4.7. Competitive Landscape and Market Positioning
4.8. Market Opportunity Analysis
Chapter 5. Market Segmentation 1: By Device Type Estimates & Trend Analysis
5.1. Device Type & Market Share, 2026 & 2035
5.2. Market Size (Value US$ Mn) & Forecasts and Trend Analysis, 2026 to 2035, by Device Type:
5.2.1. Membrane-to-Membrane Systems
5.2.2. Needleless and Luer-Lock Systems
5.2.3. Vial Adaptors and Access Devices
5.2.4. Syringe and Bag Spike Connectors
Chapter 6. Market Segmentation 2: By Component Estimates & Trend Analysis
6.1. Component & Market Share, 2026 & 2035
6.2. Market Size (Value US$ Mn) & Forecasts and Trend Analysis, 2026 to 2035, by Component:
6.2.1. Vial Access Devices
6.2.2. Syringe Safety Devices
6.2.3. Bag and Line Access Devices
6.2.4. Accessories
Chapter 7. Market Segmentation 3: By Application Estimates & Trend Analysis
7.1. Application & Market Share, 2026 & 2035
7.2. Market Size (Value US$ Mn) & Forecasts and Trend Analysis, 2026 to 2035, by Application:
7.2.1. Hazardous Drug Compounding and Administration (Oncology)
7.2.2. Antiviral, Immunosuppressant and Other Hazardous Drugs
7.2.3. Veterinary Oncology and Other Applications
Chapter 8. Market Segmentation 4: By End User Estimates & Trend Analysis
8.1. End User & Market Share, 2026 & 2035
8.2. Market Size (Value US$ Mn) & Forecasts and Trend Analysis, 2026 to 2035, by End User:
8.2.1. Hospitals and Oncology Pharmacies
8.2.2. Ambulatory Infusion Centers
8.2.3. Home Healthcare and Compounding Pharmacies
Chapter 9. Closed System Transfer Devices (CSTD) Market: Regional Estimates & Trend Analysis
9.1. North America
9.1.1. United States
9.1.2. Canada
9.2. Europe
9.2.1. Germany
9.2.2. United Kingdom
9.2.3. France
9.2.4. Italy
9.2.5. Spain
9.2.6. Rest of Europe
9.3. Asia Pacific
9.3.1. China
9.3.2. Japan
9.3.3. India
9.3.4. South Korea
9.3.5. Australia
9.3.6. Southeast Asia
9.3.7. Rest of Asia Pacific
9.4. Latin America
9.4.1. Brazil
9.4.2. Mexico
9.4.3. Rest of Latin America
9.5. Middle East & Africa
9.5.1. GCC Countries
9.5.2. South Africa
9.5.3. Rest of Middle East & Africa
Chapter 10. Competitive Landscape
10.1. Company Market Positioning Analysis
10.2. Strategic Developments (Partnerships, Expansions, Product Launches, M&A)
Chapter 11. Company Profiles
11.1. Becton, Dickinson and Company
11.2. ICU Medical, Inc.
11.3. B. Braun Melsungen AG
11.4. Equashield LLC
11.5. Corvida Medical
11.6. Simplivia Healthcare Ltd.
11.7. Baxter International Inc.
11.8. Yukon Medical, LLC
11.9. Caragen Ltd.
11.10. JMS Co., Ltd.
11.11. Codan Medizinische Gerate GmbH & Co KG
11.12. Nipro Corporation
11.13. Tosho Inc.
11.14. Epic Medical Pte Ltd.
11.15. Terumo Corporation
圖表清單 List of Tables & Figures
Table 1. Global Closed System Transfer Devices (CSTD) Market Revenue Forecast by Device Type, 2026-2035 (US$ Mn)
Figure 1. Global Closed System Transfer Devices (CSTD) Market Segmentation and Scope Overview
Table 2. Global Closed System Transfer Devices (CSTD) Market Revenue Forecast by Component, 2026-2035 (US$ Mn)
Figure 2. Global Closed System Transfer Devices (CSTD) Market Share by Device Type, 2026 & 2035
Table 3. Global Closed System Transfer Devices (CSTD) Market Revenue Forecast by Application, 2026-2035 (US$ Mn)
Figure 3. Regulatory Standards for Hazardous Drug Handling and Closed System Adoption by Region
Table 4. Global Closed System Transfer Devices (CSTD) Market Revenue Forecast by End User, 2026-2035 (US$ Mn)
Figure 4. Containment Technology Comparison: Physical Barrier, Air-Cleaning and Needleless Designs
Table 5. Global Closed System Transfer Devices (CSTD) Market Revenue Forecast by Region, 2026-2035 (US$ Mn)
Figure 5. Asia Pacific Closed System Transfer Devices (CSTD) Growth Opportunity Analysis
Table 6. North America Closed System Transfer Devices (CSTD) Market Revenue by Country, 2026-2035 (US$ Mn)
Figure 6. Competitive Positioning of Key Closed System Transfer Devices (CSTD) Market Participants
Table 7. Europe Closed System Transfer Devices (CSTD) Market Revenue by Country, 2026-2035 (US$ Mn)
Figure 7. Porter's Five Forces Analysis of the Global Closed System Transfer Devices (CSTD) Market
Table 8. Asia Pacific Closed System Transfer Devices (CSTD) Market Revenue by Country, 2026-2035 (US$ Mn)
Figure 8. Oncology Infusion Volumes and Per-Dose Closed System Device Demand, 2026-2035
Table 9. Strategic Developments of Leading Closed System Transfer Devices (CSTD) Market Participants, 2023-2026
提及公司
常見問題
這份報告可以先索取樣本嗎？
可以。建議購買前先申請樣本，提出申請後約 2 個工作天內提供，您可以先確認內容涵蓋範圍是否符合需求。
報告價格如何計算？
報告以美元標價，台幣報價依當日匯率換算並加計 5% 營業稅。不同授權版本（單人／多人／企業全站）價格不同，量子訊息會評估您的使用情境後提供最優惠報價。
下單後多久交付？如何付款？
一般 3–7 個工作天交付，實際依出版商狀況於下單前確認。收到報告確認無誤後開立台幣發票，30 天內電匯付款即可。
量子訊息有限公司為 InsightAce Analytic 在台灣的授權代理，提供報告購買、樣本申請與授權諮詢。電話 +886 2 7751 5192 ・ 聯絡我們